About Redicine Medsol
Redicine Medsol is a Healthcare company based in Ahmedabad (India) founded in 2020 by Dhaumil Parmar, Kush Prajapati, Harsh Mangukiya, and Raj Urvish Shah. Medical adherence devices are supplied for cardiac and cancer patients. Redicine Medsol has raised $97.25 thousand across 1 funding round from investors including Ducon Consultants, Las Olas and Unitve Ventures. The company has 1 employees. Redicine Medsol was last valued at $1.07 million in October 2022. Its chief executive, as recorded, is Kush Prajapati. Its Indian entity Redicine Medsol Private Limited reported revenue of ₹4.4 Lakh. Redicine Medsol offers products and services including ReMed+ and Redicine App. Its focus areas include HealthTech, Disease Self Management, Medication Adherence and Device.
Company details
Redicine Medsol was founded in 2020 and is based in Ahmedabad, India. Operations focus on the health technology sector, where medical adherence devices are developed for patients with cardiac and cancer conditions. Smart pill boxes are offered to organize and store medications, deliver reminders through connected mobile devices, and produce detailed reports on consumption patterns. Services target improved medication management in clinical settings.
- Headquarters Ahmedabad, India
- Employees 1
- Founders Dhaumil Parmar, Kush Prajapati, Harsh Mangukiya, Raj Urvish Shah
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website redicinemedsol.com
- Social LinkedIn X Facebook Instagram
- Legal Name Redicine Medsol Private Limited
- Date of Incorporation 29 Jun, 2020
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹4.4 Lakh
FY 2025 · -74% YoY
- Net Loss-₹40.7 Lakh
FY 2025 · -918% margin
- EBITDA-₹39.4 Lakh
FY 2025 · -888% margin
- Total Equity Funding$97.25K (USD)
in 1 rounds
- Latest Funding Round$97.25K (USD), Seed
Oct 2022
- InvestorsDucon Consultants
& 6 more
- Employee Count1
Associated legal entities of Redicine Medsol
Redicine Medsol operates through Redicine Medsol Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Redicine Medsol Private Limited CIN U33100GJ2020PTC114237 | Active | 29 Jun 2020 | Ahmedabad, Gujarat | ₹0.0 Cr | 3 | View details |
Products & Services of Redicine Medsol
Redicine Medsol offers a comprehensive portfolio of products and services, including ReMed+ and Redicine App.
Device for organizing medications with reminders to prevent errors.
App for sending smart reminders and tracking adherence to medications.
Funding Insights of Redicine Medsol
Redicine Medsol has successfully raised a total of $97.25K through 1 strategic funding round. The most recent funding activity was a Seed round of $97.25 thousand completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $97,248
- Total Rounds 1
- Last Round Seed — $97,248
- First Round $97,248
(Oct 2022)
- Investors Count 7
All 1 funding rounds of Redicine Medsol with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | $97,248 | Seed | $1.07M | Las Olas, Unitve Ventures |
| Date | Valuation | Stage |
|---|---|---|
| Oct 2022 | $1.07M | •••••••• |
Last known valuation $1.07M (Oct 2022). 7 investors in total: 4 institutional and 3 angel.
Investors in Redicine Medsol
Redicine Medsol has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Ducon Consultants, Las Olas and Unitve Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments in US tech and life sciences are targeted. | lasolasvc.com | Fort Lauderdale, United States | ||
Provider of diversified management consulting services | Ahmedabad, India | |||
Structural and industrial design services with expertise in buildings and manufacturing projects. | 1988 | duconconsultants.in | Ahmedabad, India | |
SB Shital Bhavik Patel | unknown_3b939c039c634e539 | |||
TP Tarang Pallav Chokhani | unknown_a94aad6fa42a43609 | |||
RS Rita Shreeraj Mehta | unknown_60a7bcb522d049c2a |
Investor details for Redicine Medsol
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Redicine Medsol Private Limited (Redicine Medsol)
Redicine Medsol Private Limited is the primary company behind Redicine Medsol. The board of Redicine Medsol Private Limited currently have 3 directors; the longest-serving is Dhaumil Dipakkumar Parmar, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dhaumil Dipakkumar Parmar DIN 08775645 | Director | 29 Jun 2020 | 6 yrs 4 mo | Redicine Medsol Private Limited |
| Kush Kirtikumar Prajapati DIN 08775643 | Director | 29 Jun 2020 | 6 yrs 4 mo | Redicine Medsol Private Limited |
| Raj Urvish Shah DIN 09375563 | Director | 01 Apr 2022 | 4 yrs 7 mo | Redicine Medsol Private Limited |
People of Redicine Medsol
4 people are tracked at Redicine Medsol (4 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CSO | Leadership | |
| Co-Founder & CEO | Leadership | |
| Co-Founder & CTO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Redicine Medsol
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Redicine Medsol
Figures of Redicine Medsol Private Limited, the primary company behind Redicine Medsol, for FY 2025. Revenue was ₹4.4 Lakh (-74% year on year). Net loss was -₹40.7 Lakh (-918% margin). EBITDA was -₹39.4 Lakh (-888% margin).
- ₹4.4 LakhRevenue · FY 2025 · -74% YoY
- -₹40.7 LakhNet loss · -918% margin
- -₹39.4 LakhEBITDA · -888% margin
- ₹56,640Paid-up capital
Balance sheet, profit and loss, cash flow and ratios of Redicine Medsol Private Limited are on its company page.
Detailed financial statements for Redicine Medsol
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Redicine Medsol
3 dated milestones of Redicine Medsol across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Redicine Medsol is founded.
- Funding First funding round of $97K.
- Milestone Reaches Minicorn status.
Web traffic of Redicine Medsol
The website of Redicine Medsol (redicinemedsol.com) receives about 5.4K visits a month.
- Monthly visits5.4K
▲ 447.3% vs previous month
Top companies in Health Monitoring & Wearables
3 companies that operate in the same segment as Redicine Medsol (Health Monitoring & Wearables) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
AI-powered EMR, EHR, and patient engagement solutions are provided. | 2020 | Bengaluru, Karnataka, India | USD 19.5 M | USD 3.36 M | 117 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Redicine Medsol
Redicine Medsol was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Redicine Medsol is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Kush Prajapati is the CEO of Redicine Medsol, as recorded in our data. They have also founded this company.
Redicine Medsol is a funded company, having raised a total of $97.25K across 1 funding round to date. The company's 1st funding round was a Seed of $97.25K, raised on Oct 2022.
Redicine Medsol has 1 employees.
The primary company behind Redicine Medsol, Redicine Medsol Private Limited, reported revenue of ₹4.4 Lakh for FY 2025, down 74% year on year.
Redicine Medsol was founded in 2020 and is based in Ahmedabad, India. Operations focus on the health technology sector, where medical adherence devices are developed for patients with cardiac and cancer conditions. Smart pill boxes are offered to organize and store medications, deliver reminders through connected mobile devices, and produce detailed reports on consumption patterns. Services target improved medication management in clinical settings.
Redicine Medsol offers ReMed+ and Redicine App.
Redicine Medsol has 7 investors. Key investors include Ducon Consultants, Las Olas, Unitve Ventures, Shital Bhavik Patel, and Tarang Pallav Chokhani.
The valuation of Redicine Medsol is $1.07M as of Oct 2022.
Redicine Medsol operates through Redicine Medsol Private Limited.
The legal entities of Redicine Medsol currently have 3 directors, including Raj Urvish Shah, Dhaumil Dipakkumar Parmar, Kush Kirtikumar Prajapati.